Physician profile
Nicholas Laskay
NPI 1396242285
$2,074.16
in general payments reported to CMS, 2019-2025
5 companies · $1,056 in 2025
The $1,056 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $150 · 2022: $309 · 2023: $243 · 2024: $316 · 2025: $1,056.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,569 · Travel and Lodging: $46.72.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,568.60 |
| Travel and Lodging | $46.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,163.57 | 2021-2025 | Mazor X System, Cd Horizon Spinal System, Adaptix Interbody System With Titan Nanolock Surface Technology |
| Stryker Corporation | $430.37 | 2023-2025 | Aleutian Interbody Systems, Cascadia Interbody System, Core |
| Depuy Synthes Sales INC. | $343.80 | 2024-2025 | Symphony, Teligen, Expedium |
| Nuvasive, INC. | $118.70 | 2022-2023 | Xlif |
| Gotham Surgical Solutions & Devices, INC. | $17.72 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Laskay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.